Partnerships increase WBE testing success

March 13, 2023

Wastewater-Based Epidemiology (WBE) has transformed the landscape in tracking the spread of SARS-CoV-2 variants at the community level, according to Sarah Kane, Director of Research and Development at GT Molecular. Her article, “Wastewater Surveillance: It Takes a Village,” is in the February volume of the Water Environment and Technology Journal.

This success has been the result of increased testing capacity through partnerships created by public health and private sectors, as well as technological innovations increasing test sensitivity and accuracy. With the widespread sharing of results data, public health decisions can be made with greater transparency, building trust between the various stakeholders. In the future, WBE will be expanded through these partnerships to include other infectious diseases such as MPox, RSV and Antimicrobial Resistant bacteria. 

GT Molecular utilizes Ceres Nanosciences Nanotrap® Microbiome Particles and enhancement reagents for the initial microorganism capture and concentration procedure prior to nucleic acid extraction and analysis. The high affinity hydrogel particles capture and concentrate the entire microorganism, resulting in more comprehensive sequencing of genomes for variant identification and earlier detection of microorganisms in wastewater samples. The capture and concentration process with Nanotrap Microbiome Particles is much faster than using traditional methods, leading to increased sample throughput and faster test turnaround times.

Read the article

Nanotrap® Microbiome Particles (For Research Use Only. Not for use in diagnostic procedures.), distributed by Streck, offer a simple and rapid approach for concentration of SARS-Co-V-2 from large volume wastewater samples.

Nanotrap Microbiome A Particles

Nanotrap Microbiome Particles concentrate SARS-CoV-2 from wastewater samples without ultracentrifugation or filtration.

Learn more
streck
Molecular

New antibiotic fights antimicrobial resistant bacteria

Recent work published in Nature has introduced Zosurabalpin, a new antibiotic effective against Carbapenem-resistant Acinetobacter baumannii (CRAB). D…
Read More
Molecular

2022 HAI Progress Report released by the CDC

When it comes to public health and health care, improvement of patient safety and prevention of adverse events are top priorities for the Centers for …
Read More
Molecular

CDC expands disease surveillance at major U.S. airports

U.S. airports host more than 1 billion visitors each year, and it’s not just people. New and emerging bacteria, viruses and other microbes travel th…
Read More